Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors
Phase 1 1 First-In-Human study designed to assess safety , tolerability , right dose for Phase
Phase 1 1 First-In-Human study designed to assess safety , tolerability , right dose for Phase
LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) (‘LaFleur Minerals’ or the ‘Company’) is pleased to provide the results of its
triumph gold Corp. (TSXV: TIG) (OTC Pink: TIGCF) (FSE: 8N6) (‘triumph gold’ or the ‘Company’) is pleased to announce the acquisition of
Metro Mining (MMI:AU) has announced Operational Update Download the PDF here. This post appeared first on investingnews.com
Cryptocurrency investors have experienced a real rollercoaster in the last few years — the likes of Bitcoin, Ethereum and Ripple have had
Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com
Adam Rozencwajg, managing partner at Goehring & Rozencwajg, shares his latest thoughts on the gold, silver and uranium markets, also discussing why
A Malian court has postponed a critical decision on whether to place Barrick Mining’s (TSX:ABX,NYSE:B) flagship Loulo-Gounkoto gold complex under provisional administration The
Chinese researchers have unveiled a method of extracting uranium from seawater at a fraction of the previous cost and energy use, positioning
Rio Tinto (ASX:RIO,NYSE:RIO,LSE:RIO) announced on May 22 that Chief Executive Jakob Stausholm will step down later this year following a formal succession